Certificate of Supplementary Protection Regulations
Marginal note:Definition of Act
1 (1) In these Regulations, Act means the Patent Act.
Marginal note:Definition of authorization for sale
(2) In these Regulations and for the purposes of section 104 of the Act, authorization for sale means an authorization under the Food and Drugs Act, or any predecessor enactment relating to the same subject matter, that permits the sale of a drug in Canada, but does not include an interim order permitting the sale of a drug under section 30.1 of that Act, a certificate issued under section C.08.015 of the Food and Drug Regulations, an exemption under subsection C.10.002(1) or C.10.008(1) of those Regulations or an authorization under section C.05.006, C.05.008 or C.08.010 or subsection C.11.003(1) or C.11.014(1) of those Regulations, section 67 or 71 of the Natural Health Products Regulations or section 21 or subsection 24(2) of the Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations.
- SOR/2021-199, s. 8
- SOR/2022-18, s. 53
- SOR/2022-18, s. 54
- SOR/2023-18, s. 6
- Date modified: